Reports for APOTEX INC
Company Name APOTEX INC |
||
|---|---|---|
Totals |
||
Shortage reports |
3367 |
|
| Actual shortage: | 219 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3138 (93%) | |
Discontinuation Reports |
365 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 341 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
67 (28%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-IMATINIB | 100MG | TABLET | Resolved | 2024-11-14 | 2025-01-17 | 243083 |
| APO-IMATINIB | 400MG | TABLET | Resolved | 2018-07-31 | 2018-11-15 | 56986 |
| APO-IMATINIB | 400MG | TABLET | Resolved | 2018-11-30 | 2019-01-10 | 68221 |
| APO-IMATINIB | 400MG | TABLET | Resolved | 2019-03-13 | 2019-03-29 | 78512 |
| APO-IMATINIB | 400MG | TABLET | Resolved | 2017-07-31 | 2017-09-06 | 17609 |
| APO-IMATINIB | 100MG | TABLET | Resolved | 2021-01-29 | 2021-02-11 | 132718 |
| APO-IMATINIB | 400MG | TABLET | Resolved | 2022-02-18 | 2022-03-21 | 155314 |
| APO-IMATINIB | 100MG | TABLET | Resolved | 2022-04-08 | 2022-06-02 | 158358 |
| APO-IMATINIB | 400MG | TABLET | Resolved | 2022-04-08 | 2022-06-03 | 158361 |
| APO-IMATINIB | 400MG | TABLET | Resolved | 2017-11-28 | 2018-04-18 | 31010 |
| APO-IMATINIB | 400MG | TABLET | Resolved | 2021-04-16 | 2021-05-17 | 137578 |
| APO-IMATINIB | 400MG | TABLET | Resolved | 2021-06-25 | 2021-07-12 | 141532 |
| APO-IMIQUIMOD | 5% | CREAM | Resolved | 2017-03-10 | 2019-11-26 | 333 |
| APO-INDAPAMIDE 1.25 MG TABLETS | 1.25MG | TABLET | Resolved | 2017-05-04 | 2017-12-14 | 8865 |
| APO-INDAPAMIDE 1.25 MG TABLETS | 1.25MG | TABLET | Resolved | 2021-07-23 | 2021-08-31 | 142979 |
| APO-INDAPAMIDE 1.25 MG TABLETS | 1.25MG | TABLET | Resolved | 2017-07-17 | 2017-12-14 | 15973 |
| APO-INDAPAMIDE 1.25 MG TABLETS | 1.25MG | TABLET | Resolved | 2023-09-07 | 2023-11-24 | 203846 |
| APO-INDAPAMIDE 1.25 MG TABLETS | 1.25MG | TABLET | Resolved | 2021-02-05 | 2021-04-05 | 133379 |
| APO-INDAPAMIDE 1.25 MG TABLETS | 1.25MG | TABLET | Resolved | 2023-05-12 | 2023-05-26 | 192370 |
| APO-INDAPAMIDE 1.25 MG TABLETS | 1.25MG | TABLET | Resolved | 2019-09-25 | 2020-03-02 | 94740 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| NAPROXEN SODIUM TABLETS | 220MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71228 |
| PENTOXIFYLLINE SR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-23 | 2022-01-27 | 65438 |
| TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
| TEMAZEPAM | 30MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65482 |
| TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |